DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.
The global Drug Metabolism and Pharmacokinetics (DMPK) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
ReportPrime’s newest research report, the “Drug Metabolism and Pharmacokinetics (DMPK) Industry Forecast” looks at past sales and reviews total world Drug Metabolism and Pharmacokinetics (DMPK) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Metabolism and Pharmacokinetics (DMPK) sales for 2023 through 2029. With Drug Metabolism and Pharmacokinetics (DMPK) sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Metabolism and Pharmacokinetics (DMPK) industry.
This Insight Report provides a comprehensive analysis of the global Drug Metabolism and Pharmacokinetics (DMPK) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Metabolism and Pharmacokinetics (DMPK) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Metabolism and Pharmacokinetics (DMPK) market.
- Segmentation by Type:
- Small Molecules
- Biologics
- Segmentation by Application:
- Biopharmaceutical Companies
- Government and Academic Institutes
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:
- Eurofins Discovery
- Inotiv
- Evotec
- Sai Life Sciences
- Sygnature Discovery
- WuXi AppTec
- Hangzhou Tigermed Consulting Co
- Q2 Solutions
- Jubilant Biosys
- Frontage Laboratories
- Invitrocue
- Creative Biolabs
- CrownBioscience
- Agilent
- H3D
- LABCORP
- Bioduro-Sundia
- Allucent
Key Questions Addressed in this Report:
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market